Published in J Urol on October 01, 2011
Editorial comment. J Urol (2011) 0.75
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med (2010) 10.90
Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med (2011) 5.31
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. N Engl J Med (2015) 3.64
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis (2012) 2.42
Microbicides & their implications in HIV prevention. Indian J Med Res (2010) 2.36
Is VCUG still indicated following the first episode of urinary tract infection in boys? Urology (2012) 2.03
Results: Survey of pediatric urology electronic medical records-use and perspectives. J Urol (2011) 2.02
Preventing HIV infection in women: a global health imperative. Clin Infect Dis (2010) 1.47
Effect of rectal distention on lower urinary tract function in children. J Urol (2010) 1.46
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. Trials (2011) 1.15
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol (2011) 1.13
A novel technique for ureteral catheterization and/or retrograde ureteroscopy after cross-trigonal ureteral reimplantation. J Urol (2003) 1.07
Utilizing nucleic acid amplification to identify acute HIV infection. AIDS (2007) 1.07
Global epidemiology of HIV-AIDS. Infect Dis Clin North Am (2007) 1.06
Adherence in the CAPRISA 004 tenofovir gel microbicide trial. AIDS Behav (2014) 1.06
When to start antiretroviral therapy during tuberculosis treatment? Curr Opin Infect Dis (2013) 0.94
Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antivir Ther (2012) 0.94
Topical microbicides--what's new? J Acquir Immune Defic Syndr (2013) 0.92
Pathogenesis of renal injury in the megabladder mouse: a genetic model of congenital obstructive nephropathy. Pediatr Res (2010) 0.91
Antiretroviral therapy: challenges and options in South Africa. Lancet (2003) 0.91
Overview of microbicides for the prevention of human immunodeficiency virus. Best Pract Res Clin Obstet Gynaecol (2012) 0.90
Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation. J Acquir Immune Defic Syndr (2017) 0.89
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. S Afr Med J (2010) 0.85
Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children. J Urol (2012) 0.83
Novel management of urinary tract infections. Curr Opin Urol (2011) 0.82
A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection. Expert Opin Investig Drugs (2012) 0.82
In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens. J Urol (2011) 0.81
Microbicides for the prevention of sexually transmitted HIV infection. Expert Rev Anti Infect Ther (2013) 0.78
Microbicides for prevention of HIV infection: clinical efficacy trials. Curr Top Microbiol Immunol (2014) 0.77
Antibodies for HIV prevention in young women. Curr Opin HIV AIDS (2015) 0.77
Nocturnal bladder emptying for reversing urinary tract deterioration due to neurogenic bladder. Curr Urol Rep (2007) 0.75
Pathophysiology and management of urinary incontinence in case of distal penile epispadias. J Urol (2008) 0.75
Diuretic radionuclide urography: a non-invasive method for evaluating nephroureteral dilatation. 1979. J Urol (2002) 0.75